Toll-like Receptor Agonist
Antibody Conjugate (TRAAC)

Tallac’s novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform enables systemic delivery of a differentiated, targeted TLR9 agonist (T-CpG) for immune activation.

TRAAC